Ondansetron ODT 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FJB3L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,991
Award facts
- Contract value 100% obligated
- $28,991.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $29,000 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT (orally disintegrating tablets) 4 mg in quantities of 30 tablets. The contract, which is non-competitive and firm fixed price, was executed on November 28, 2025, with an ultimate completion date of December 1, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same city. This delivery order represents one of numerous competitive awards the company has received through the Defense Logistics Agency's Medical Supply Chain, demonstrating its role as a critical vendor for federal pharmaceutical procurement.
This delivery order operates as a child contract under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. That prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, generic drugs, vaccines, and related commodities across multiple therapeutic domains. The company serves various federal healthcare customers including the Defense Health Agency and the U.S. Coast Guard through this flexible contracting mechanism, which positions it among multiple anticipated prime vendors in the DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative.
Quick answers
Who was awarded contract SPE2DR26FJB3L?
SPE2DR26FJB3L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 28, 2025.
How much is contract SPE2DR26FJB3L worth?
The government has obligated $28,991 on SPE2DR26FJB3L.
Is contract SPE2DR26FJB3L an order under another contract?
Yes. SPE2DR26FJB3L is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJB3L competed?
The extent of competition for SPE2DR26FJB3L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award